J M Gorman1, J M Kent, G M Sullivan, J D Coplan. 1. Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, USA. jmg9@columbia.edu
Abstract
OBJECTIVE: In a 1989 article, the authors provided a hypothesis for the neuroanatomical basis of panic disorder that attempted to explain why both medication and cognitive behavioral psychotherapy are effective treatments. Here they revise that hypothesis to consider developments in the preclinical understanding of the neurobiology of fear and avoidance. METHOD: The authors review recent literature on the phenomenology, neurobiology, and treatment of panic disorder and impressive developments in documenting the neuroanatomy of conditioned fear in animals. RESULTS: There appears to be a remarkable similarity between the physiological and behavioral consequences of response to a conditioned fear stimulus and a panic attack. In animals, these responses are mediated by a "fear network" in the brain that is centered in the amygdala and involves its interaction with the hippocampus and medial prefrontal cortex. Projections from the amygdala to hypothalamic and brainstem sites explain many of the observed signs of conditioned fear responses. It is speculated that a similar network is involved in panic disorder. A convergence of evidence suggests that both heritable factors and stressful life events, particularly in early childhood, are responsible for the onset of panic disorder. CONCLUSIONS: Medications, particularly those that influence the serotonin system, are hypothesized to desensitize the fear network from the level of the amygdala through its projects to the hypothalamus and the brainstem. Effective psychosocial treatments may also reduce contextual fear and cognitive misattributions at the level of the prefrontal cortex and hippocampus. Neuroimaging studies should help clarify whether these hypotheses are correct.
OBJECTIVE: In a 1989 article, the authors provided a hypothesis for the neuroanatomical basis of panic disorder that attempted to explain why both medication and cognitive behavioral psychotherapy are effective treatments. Here they revise that hypothesis to consider developments in the preclinical understanding of the neurobiology of fear and avoidance. METHOD: The authors review recent literature on the phenomenology, neurobiology, and treatment of panic disorder and impressive developments in documenting the neuroanatomy of conditioned fear in animals. RESULTS: There appears to be a remarkable similarity between the physiological and behavioral consequences of response to a conditioned fear stimulus and a panic attack. In animals, these responses are mediated by a "fear network" in the brain that is centered in the amygdala and involves its interaction with the hippocampus and medial prefrontal cortex. Projections from the amygdala to hypothalamic and brainstem sites explain many of the observed signs of conditioned fear responses. It is speculated that a similar network is involved in panic disorder. A convergence of evidence suggests that both heritable factors and stressful life events, particularly in early childhood, are responsible for the onset of panic disorder. CONCLUSIONS: Medications, particularly those that influence the serotonin system, are hypothesized to desensitize the fear network from the level of the amygdala through its projects to the hypothalamus and the brainstem. Effective psychosocial treatments may also reduce contextual fear and cognitive misattributions at the level of the prefrontal cortex and hippocampus. Neuroimaging studies should help clarify whether these hypotheses are correct.
Authors: Luana T Lopes; Luis G A Patrone; Kênia C Bícego; Norberto C Coimbra; Luciane H Gargaglioni Journal: Pflugers Arch Date: 2012-06-05 Impact factor: 3.657
Authors: Thomas Dresler; Anne Guhn; Sara V Tupak; Ann-Christine Ehlis; Martin J Herrmann; Andreas J Fallgatter; Jürgen Deckert; Katharina Domschke Journal: J Neural Transm (Vienna) Date: 2012-06-13 Impact factor: 3.575
Authors: Oliver Tuescher; Xenia Protopopescu; Hong Pan; Marylene Cloitre; Tracy Butler; Martin Goldstein; James C Root; Almut Engelien; Daniella Furman; Michael Silverman; Yihong Yang; Jack Gorman; Joseph LeDoux; David Silbersweig; Emily Stern Journal: J Anxiety Disord Date: 2010-11-13
Authors: K R Engel; K Obst; B Bandelow; P Dechent; O Gruber; I Zerr; K Ulrich; D Wedekind Journal: Eur Arch Psychiatry Clin Neurosci Date: 2015-11-19 Impact factor: 5.270
Authors: Larry Sandberg; Fredric Busch; Franklin Schneier; Andrew Gerber; Eve Caligor; Barbara Milrod Journal: Harv Rev Psychiatry Date: 2012 Sep-Oct Impact factor: 3.732
Authors: Dean Mobbs; Predrag Petrovic; Jennifer L Marchant; Demis Hassabis; Nikolaus Weiskopf; Ben Seymour; Raymond J Dolan; Christopher D Frith Journal: Science Date: 2007-08-24 Impact factor: 47.728
Authors: Ilse Van Diest; Margaret M Bradley; Pedro Guerra; Omer Van den Bergh; Peter J Lang Journal: Biol Psychol Date: 2008-10-07 Impact factor: 3.251